Cargando…
Reversal of Dialysis-Dependent Anti–Glomerular Basement Membrane Disease Using Plasma Exchange, Glucocorticosteroids, and Rituximab
Autores principales: | Lemahieu, Wim, Ombelet, Sara, Lerut, Evelyne, Jamar, Sofie, Sprangers, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127412/ https://www.ncbi.nlm.nih.gov/pubmed/30197991 http://dx.doi.org/10.1016/j.ekir.2018.04.015 |
Ejemplares similares
-
Rituximab for Anti–Glomerular Basement Membrane Disease
por: Jain, Rashmi, et al.
Publicado: (2018) -
Beneficial Effect of Rituximab in the Treatment of Esophageal Cancer–Associated Pauci-Immune Glomerulonephritis
por: Ameye, Heleen, et al.
Publicado: (2016) -
Binding Truths: Seronegative Anti-Glomerular Basement Membrane Disease Mediated by IgM Anti-Glomerular Basement Membrane Antibodies
por: Antonelou, Marilina, et al.
Publicado: (2023) -
Eculizumab and Complement Activation in Anti−glomerular Basement Membrane Disease
por: Nithagon, Pravarut, et al.
Publicado: (2021) -
A Case of Glomerulopathy Associated With Monoclonal Glomerular Basement Membrane Antibody
por: Bonilla, Marco, et al.
Publicado: (2021)